Janssen Sciences Ireland UC

Clinical trials sponsored by Janssen Sciences Ireland UC, explained in plain language.

Now part of Johnson & Johnson JNJ NYSE

Pharmaceutical research and development subsidiary of Johnson & Johnson.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

HIV drug rilpivirine keeps helping kids in Long-Term study

Disease control Ongoing

This study gives children with HIV-1 who previously benefited from rilpivirine continued access to the drug along with other antiretrovirals. About 48 kids are taking part to monitor long-term safety and side effects. The goal is to keep their virus under control while checking f…

Phase 2 • Sponsor: Janssen Sciences Ireland UC • Aim: Disease control

Last updated Aug 30, 2026 00:00 UTC

Janssen Sciences Ireland UC

HIV drug rilpivirine keeps helping kids in Long-Term study